†A responder was defined as a patient with 3 or more SBMs per week, with an increase of 1 or more SBM(s) per week over baseline, for 3 or more out of the first 4 weeks of the treatment period.
‡Three RELISTOR 150-mg tablets (450 mg total) once daily in the morning with water on an empty stomach at least 30 minutes before the first meal of the day.
llA responder was defined as a patient with 3 or more SBMs per week for each of the 4 weeks in the double-blind period.
¶Defined as bowel movement without the use of any laxative in previous 24 hours.
SBM=spontaneous bowel movement.
Learn more about dosing and administration of RELISTOR tablets
Learn more about dosing and administration of RELISTOR injection
If your patients are taking opioids for chronic pain, they might be experiencing Painstipation, the constipation caused by opioids. This is more commonly referred to as opioid-induced constipation (OIC).1
Help provide reliable, rapid relief with RELISTOR—the only PAMORA* that is not metabolized via the CYP3A4 pathway.1,2
PAMORA=peripherally acting mu-opioid receptor antagonist.
*Approved for OIC.
Please click here for full Prescribing Information for RELISTOR tablets and RELISTOR injection.